Kinled Holding

Xapien is a company that specializes in automating online research through the use of artificial intelligence and natural language processing. Its platform is designed to assist in third-party risk management by delivering on-demand research on individuals and companies worldwide. By leveraging extensive cloud computing capabilities, Xapien enables clients to build efficient internal research capacities that provide deep contextual insights. This approach not only enhances decision-making but also reduces costs associated with internal and outsourced research efforts.

Connect Earth, founded in 2021 and based in London, is an environmental data company focused on providing accessible sustainability information. The company has developed a carbon tracking API that enables users to understand the environmental impact of their purchases, offering detailed insights into carbon emissions and facilitating the calculation of carbon footprints. By partnering with financial institutions, Connect Earth empowers consumers to make informed, sustainable choices in their daily spending and promotes transparency regarding the climate effects of financial activities. The company's mission is to bridge the gap between environmental intent and actionable knowledge, thereby driving sustainable finance and helping both individuals and businesses reduce their carbon emissions.

OneTrust, LLC is a technology company that specializes in privacy management and compliance solutions. Founded in 2016 and headquartered in Atlanta, Georgia, the company offers a comprehensive platform that automates various aspects of privacy program management, including privacy impact assessments, data inventory mapping, and risk remediation actions. OneTrust’s solutions facilitate compliance with global regulations by providing tools for vendor risk management, incident reporting, and website compliance, as well as managing data subject rights and consent. The platform serves a diverse clientele ranging from multinational corporations to small and medium enterprises, allowing them to collaborate effectively on privacy risks associated with customer, employee, and vendor data. OneTrust also provides training and certification programs, ensuring that organizations can maintain continuous compliance through ongoing audits and assessments. With additional offices worldwide, OneTrust is positioned to support businesses in navigating the complexities of privacy regulations across various sectors and jurisdictions.

Nanoflex Robotics is a MedTech startup established in 2021 that focuses on developing a telerobotic platform for remote Mechanical Thrombectomy, aimed at treating ischemic strokes. The company's innovative technology facilitates quicker remote treatments, which can improve patient outcomes and enhance health equity. Additionally, it offers benefits to hospitals by potentially increasing profitability. Nanoflex Robotics has received positive feedback from notable clinical partners, including the Jacobs Institute, Mayo Clinic, and Toronto Health. The firm has also created a proprietary soft robotic system designed to navigate complex vascular anatomy using precise electromagnetic fields, enabling physicians to effectively diagnose and treat vascular diseases such as acute ischemic stroke.

Hi.health is focused on transforming the claims process in private health insurance by addressing inefficiencies and enhancing cost control for insurers. The company offers a solution that includes co-branded debit cards for insurance members, allowing them to access health-related services without incurring out-of-pocket expenses. This approach not only simplifies the user experience but also provides insurers with structured data and real-time visibility into claims costs, helping to minimize fraud and operational expenses. Additionally, the platform manages invoices and prescriptions, further streamlining the insurance process and encouraging cost-conscious behavior among members. Through these innovations, Hi.health aims to deliver significant improvements in user satisfaction and substantial cost savings for insurers.

Algonist Biotechnologies is a pre-clinical stage biotechnology company focused on developing innovative small molecule therapeutics for chronic and neuropathic pain. The company's approach centers on creating non-opioid drugs that aim to provide effective pain relief while minimizing the serious side effects commonly associated with existing treatments. By specializing in oral small-molecule therapeutics, Algonist Biotechnologies strives to enhance treatment efficacy and ensure patient safety, allowing individuals to alleviate chronic pain without harming neurons in the peripheral and central nervous systems.

Cebina Bridge Capital is a venture capital investment firm established in 2021 and based in Gibraltar. The firm specializes in investing in pharmaceutical drug discovery and biotechnology projects, particularly within Central and Eastern Europe. By targeting this specific geographical area and sector, Cebina Bridge Capital aims to support and advance innovative health solutions and technologies, fostering growth in the regional biotech landscape.

Five Lives is a London-based digital therapeutics company focused on enhancing cognitive health through its innovative mobile app, Sharp. This platform is designed to help users measure and mitigate their risk of cognitive decline by promoting healthier lifestyle choices. By offering an engaging and user-friendly tool, Five Lives aims to facilitate earlier detection of dementia and empower individuals to take proactive steps in maintaining their brain health. The company’s mission is to enable users to lead longer, healthier, and more fulfilling lives by improving their overall cognitive well-being.

Master your emotions in 5 minutes a day. Ahead is a personalized pocket coach that provides bite-sized, science-driven tools to boost emotional intelligence. Think of it as a pocket cheerleader towards a better, more fulfilling, clearer-minded way of life. Most of us continuously set goals for our life - for our career, our relationships, our health. Yet, it’s damn hard to turn those goals into reality! We know - we’ve been there ourselves. That’s why we know there’s a way to make it work. And that’s what aHead is all about! Get early access: ahead-app.com

PreComb is a technology company focused on enhancing cancer treatment outcomes through innovative solutions tailored for difficult-to-treat cancers. The company has developed a 3D drug testing technology that utilizes automated microtumor-based profiling for in vitro cancer diagnosis. This technology enables clinical institutions to conduct on-site evaluations, allowing for the functional assessment of various cancer drugs, combinations, and concentrations using patient-derived micro-tumors. By optimizing the selection of therapies, PreComb aims to improve success rates in cancer treatment and ultimately enhance the quality of life for patients.

Tridek-One is a biotechnology company focused on developing immunomodulatory products aimed at treating autoimmune diseases and inflammatory disorders. The company has created a peptide that preserves a cluster of truncated CD31 molecules at the membrane, allowing for the moderation of overactive immune responses without complete blockade. This innovative approach enables medical companies to provide enhanced therapeutic options, ultimately improving patient outcomes and quality of life.

OctaiPipe is a technology company that specializes in Federated Learning Operations (FL-Ops) specifically designed for Edge AIoT devices. Its architecture streamlines the entire lifecycle of AI model development, encompassing setup, training, deployment, fine-tuning, and continuous learning. By facilitating the creation of distributed IoT solutions, OctaiPipe empowers data scientists to develop systems that learn and adapt efficiently at scale. This approach not only enhances the operational effectiveness of critical infrastructure but also promotes sustainability, resilience, and security in a globally connected environment. Furthermore, OctaiPipe's solutions significantly reduce the costs associated with monitoring, maintenance, upgrades, and auditing, making it easier for organizations to manage their AI systems.

Accelus specializes in developing medical implants aimed at enhancing minimally invasive spine surgery. The company focuses on expandable interbody technology, offering a bi-directional expandable cage that combines the strength and rigidity of a traditional monolithic implant. This innovative design allows healthcare professionals to effectively address various spinal issues, including height, weight, and lordosis problems. Accelus is dedicated to improving access to its advanced surgical solutions, particularly in markets that have been historically underserved.

Adsum is a London-based fintech company founded in 2020 that focuses on providing instant value-added tax (VAT) refunds and tax credits for businesses in the UK. The company offers a software solution that streamlines the VAT refund process through embedded software integrations with partner organizations. By leveraging artificial intelligence and machine learning, Adsum aims to simplify the tax credit process, reduce human error, and support business growth. With its innovative approach, Adsum seeks to enhance the financial efficiency of its clients by facilitating quick access to tax benefits.

BVNK is a fintech company specializing in modern payments infrastructure for businesses. It unifies traditional banking systems with blockchain technology on a single platform, enabling businesses to send and receive stablecoin payments, convert currencies, and add crypto payment options to their checkout processes. BVNK's flexible platform allows innovators to swiftly launch new payment products while ensuring compliance through its robust global licensing expertise.

Engimmune Therapeutics is a biotechnology company focused on developing innovative T cell receptor (TCR) therapies for cancer treatment, particularly targeting solid tumors. The company utilizes advanced technologies, including genome editing, high-throughput screening, deep sequencing, and machine learning, to create highly potent and specific immunotherapies. By addressing critical challenges in efficacy and safety, Engimmune aims to provide effective solutions for patients facing serious diseases with significant unmet medical needs. Through its comprehensive platform, the company is dedicated to advancing the next generation of TCR-based therapies, contributing to the evolving landscape of cancer treatment.

Memo Therapeutics AG, based in Basel, Switzerland, specializes in innovative antibody discovery and immune repertoire analysis. The company utilizes its proprietary MemoMAB platform, which generates a recombinant in vitro copy of an individual's B cell or antibody repertoire, creating extensive libraries that represent unique immune responses. These libraries are expected to contain a vast array of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics applies this technology in its own antibody lead discovery programs and partners with other entities to enhance research and development in the fields of viral infections and cancer. Through its advancements, Memo Therapeutics aims to significantly improve therapeutic options for patients.

Wiredirect is a global financial technology and FX liquidity firm that has built a whole new way to make payments across borders.

Opal is a leading screen time management application designed to help users regain control over their phone usage and improve focus. The app combines features such as app restrictions, real-time feedback, and reward systems to assist individuals in minimizing distractions and enhancing productivity. It is utilized by over 200,000 users, including teams from startups and Fortune 500 companies, all of whom rely on Opal to protect their time. The application also offers tools for tracking saved time and disconnecting from distracting applications, ultimately aiming to support mental well-being and help users achieve their goals. With a mission to assist one billion people in focusing better daily, Opal is committed to fostering a more productive and fulfilling life for its users.

CEBINA uniquely supports life science entrepreneurs and early-stage start-up companies and develops cutting-edge biotech projects.

Lapse is a social disposable camera application that allows users to capture and share photos within private group chats. The app emulates the experience of traditional disposable cameras by enabling groups to take a set of 36 photos, referred to as 'rolls.' Once the first photo is taken, the roll becomes accessible to group members for a limited time, fostering a sense of shared experience and nostalgia. This innovative approach encourages users to engage with friends while creating temporary memories that are exclusive to their group.

Acrivon Therapeutics is a clinical-stage biopharmaceutical company focused on precision oncology, developing therapeutics that target challenging cancer types without straightforward single-gene mutations. The company employs a proteomics-based platform to identify patients whose tumors are likely to respond to specific treatments. Acrivon's pipeline includes ACR-368, also known as prexasertib, which is currently in Phase 2 trials, alongside preclinical programs aimed at key components of DNA damage response and cell cycle regulation, such as the WEE1 and PKMYT1 proteins. Acrivon seeks to expedite the development of both in-licensed clinical-stage assets and its internally developed programs through accelerated registration trials, aiming to enhance treatment success in oncology.

Cobee is a Madrid-based company founded in 2018 that specializes in automating and simplifying employee benefits management. Its online platform allows businesses to streamline the administration of employee benefits and flexible compensation. Cobee provides each employee with a VISA card linked to a digital application, enabling them to pay for various expenses such as meals, transportation, daycare, training, and medical insurance. This approach not only enhances employee satisfaction but also reduces costs for companies by eliminating intermediaries and external suppliers. The platform centralizes information, improving the management and visibility of benefits, while also offering real-time insights into savings. Cobee aims to create a seamless experience for both employers and employees, allowing organizations to focus on their core operations.

FERNRIDE provides automation solutions for yard trucking that enhance productivity, sustainability, and worker safety. The company employs a human-assisted autonomy approach, allowing for remote control of trucks when necessary, which facilitates reliable operations for logistics operators. With over a decade of research and partnerships with notable clients such as Volkswagen, HHLA, and DB Schenker, FERNRIDE leverages advanced technology to tackle pressing industry issues, including driver shortages and the environmental impact of logistics. The company specializes in an autonomous, electric trucking platform that integrates teleoperations and autonomous driving technologies, enabling logistics service providers to efficiently deploy yard trucks in productive operations. Founded by Hendrik Kramer, Maximilian Fisser, and Jean-Michael Georg, FERNRIDE has grown to employ over 150 individuals.

Alentis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, focused on developing innovative therapies for advanced liver diseases, including liver fibrosis, cirrhosis, and liver cancer. Established in 2019, Alentis is recognized for its pioneering work in targeting CLDN1+ cancers through the use of anti-CLDN1 antibody-drug conjugates and other therapeutic modalities. The company's research platform incorporates clinically relevant read-outs and single-cell RNA sequencing of patient liver tissues, which aids in understanding and treating fibrotic diseases. Alentis aims to modify and reverse disease progression, ultimately addressing significant health challenges associated with liver-related conditions.

Hummingbird Bioscience is a biotechnology company specializing in the development of novel therapeutic antibodies for oncology and immuno-oncology indications. Utilizing systems biology approaches and proprietary computational platforms, they discover and engineer innovative biotherapeutics targeting challenging disease pathways with strong biological validation. Their pipeline includes lead assets HMBD-001 (anti-HER3) and HMBD-002 (anti-VISTA), both in cancer treatment. The company has formed strategic partnerships with Cancer Research UK and Amgen, and received a product development grant from the Cancer Prevention and Research Institute of Texas.

Sylvera is a carbon data provider based in London, United Kingdom, focused on promoting effective climate action. The company has developed machine learning-based tools that monitor the performance of carbon offset projects, allowing for tracking at intervals as frequent as weekly. These tools are designed to integrate seamlessly into both internal and external reporting frameworks, enabling businesses and governments to manage reputational risks while also enhancing transparency in carbon data for their customers. By providing detailed insights into the effectiveness of carbon offsets, Sylvera supports organizations in their efforts to make informed decisions about sustainability and climate initiatives.

Receeve is a customizable online platform designed for collections and recovery, aimed at simplifying the complexities of data and systems involved in credit management. The platform enables in-house teams to automate processes, engage customers, and leverage comprehensive insights to enhance debt recovery while minimizing risks. It supports all stages of credit management, from pre-delinquency to portfolio assignment and sale. Receeve's cloud-native, no-code solution is designed for quick deployment and easy management, allowing users to customize and expand functionalities as needed. By integrating intelligence, strategy, and operations into a single platform, receeve aims to improve operational effectiveness and transparency in debt servicing for companies, financial institutions, and funds of various sizes.

PreComb is a technology company focused on enhancing cancer treatment outcomes through innovative solutions tailored for difficult-to-treat cancers. The company has developed a 3D drug testing technology that utilizes automated microtumor-based profiling for in vitro cancer diagnosis. This technology enables clinical institutions to conduct on-site evaluations, allowing for the functional assessment of various cancer drugs, combinations, and concentrations using patient-derived micro-tumors. By optimizing the selection of therapies, PreComb aims to improve success rates in cancer treatment and ultimately enhance the quality of life for patients.

Gitpod is an open-source developer platform that automates the provisioning of ready-to-code development environments, enhancing productivity for engineering teams. By eliminating the need for manual setup of local development environments, Gitpod allows teams to save significant time and fosters improved collaboration in application development. The platform integrates seamlessly with popular version control services like GitLab, GitHub, and Bitbucket, automatically prebuilding development environments for all project branches. This functionality enables team members to begin coding immediately, whether they are developing new features, addressing bugs, or conducting code reviews. Gitpod's focus on automating setups allows developers to concentrate on their work, streamlining workflows and improving overall efficiency.

Bob W is a technology-driven hospitality provider that provides an alternative to hotels and short-stay apartments. Its exceptionally cool apartments cater to the 21st-century traveler who wants it all: the consistent quality of a hotel and the authentic flair and affordability of a short-stay rental. It combines both worlds in sustainably operated properties, which are currently available in Finland and Estonia but are expanding across Europe and beyond. The company was founded in 2018 and is headquartered in Helsinki, Finland.

Eirion Therapeutics is a clinical-stage biopharmaceutical company specializing in the development of advanced prescription products for aesthetic dermatology. The company's product pipeline includes treatments aimed at addressing various conditions such as wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying. Eirion is committed to meeting significant unmet clinical needs within the field, with plans to explore additional indications in the future. Through its innovative approach, Eirion Therapeutics aims to provide effective solutions for both physicians and patients dealing with aesthetic concerns.

Muse Finance operates a technology platform that connects businesses with working capital solutions, enhancing the financial experience for B2B clients. The platform offers a no-code and API integration, allowing brands to quickly implement white-label finance services. Muse Finance provides a scalable solution for finance companies to effectively manage risk and streamline the funding process. Its real-time dashboard enables businesses to oversee client funding requests and track their progress. The platform features advanced tools for cash flow forecasting and credit insights, facilitating instant credit decisions. Muse Finance offers three primary products: trade finance, buy now pay later for businesses, and invoice finance tailored for UK limited companies. Through these services, Muse Finance aims to empower small businesses with efficient fund management and future financial planning.

Cofenster specializes in automating video production through its innovative suite of Video AI assistants. These tools, designed to enhance the efficiency of Communication, HR, and Marketing teams, enable the creation of professional videos with minimal human intervention. Notable assistants include Milo, which transforms lengthy videos into engaging short clips; Ella, which generates authentic user-generated content; and Theo, which converts text into video format. Cofenster also offers a mobile application that streamlines the entire video creation process, allowing users to plan, record, and edit videos while incorporating subtitles, music, and corporate branding elements. The company serves a diverse clientele, including prominent corporations like TUI, Rewe Group, Siemens, Beiersdorf, and Vorwerk, as well as small and medium-sized enterprises.

Herophilus is engaged in the development of neurotherapeutics aimed at finding new treatments for brain disorders. The company leverages advanced technologies that combine human brain models, scaled biology, and machine learning to systematically discover and develop novel drugs with potential therapeutic applications. By employing phenotypic screening, Herophilus focuses on identifying innovative treatments for complex neurological and psychiatric conditions, including epilepsy, autism, and schizophrenia. This approach aims to enhance the ability of healthcare professionals to treat patients suffering from these brain diseases and to address the emotional symptoms associated with various neurological challenges.

HomeHero is a digital home management platform that simplifies the management of household tasks and expenses. The company offers a cloud-based system that integrates mobile and IoT technologies to streamline various services. Users can manage utility bills, household chores, and home repairs all in one place, allowing for efficient handling of maintenance issues, booking cleaners, and managing administrative tasks such as receiving packages or granting access to contractors. By providing access to online experts for live chat support, HomeHero aims to save users both time and money with a comprehensive solution for home management.

Primer API Limited operates an online platform that consolidates fragmented payment ecosystems for e-commerce merchants and online payment facilitators. Founded in 2019 and based in London, the company provides solutions to optimize both front and backend payment flows, aiming to enhance authorization rates, minimize costs, and facilitate market expansion. Primer enables users to seamlessly connect with various third-party services, including payment service providers, fraud detection systems, and subscription billing engines. Its platform allows merchants to easily integrate new payment methods, streamline fraud mitigation, and implement sophisticated transaction routing without requiring coding skills. Through these capabilities, Primer enhances the overall commerce experience for customers and empowers businesses to improve their operational efficiency.

Greyparrot is a leader in AI waste analytics, focusing on enhancing recycling efforts and minimizing waste sent to landfills and incinerators. The company offers a waste intelligence platform that provides real-time insights into over 89 waste categories, analyzing data related to financial value, brand, and greenhouse gas emissions across various locations in recycling facilities. In 2024, Greyparrot processed data from over 40 billion waste objects, significantly improving operational efficiency and enabling facilities to save substantial amounts of money while diverting millions of tonnes of waste. The insights generated by Greyparrot assist recycling professionals, plant builders, packaging producers, and fast-moving consumer goods brands in enhancing recycling efficiency, adhering to regulations, and refining recyclable packaging design. Recognized for its innovative contributions, Greyparrot has received accolades including inclusion in the Global Cleantech 100 and recognition as a Tech Pioneer by the World Economic Forum.

Corlieve Therapeutics SAS is a biotechnology company based in Paris, France, dedicated to developing innovative therapeutic options for patients suffering from severe neurological disorders. The company's primary focus is on addressing temporal lobe epilepsy (TLE) through a gene therapy approach that targets aberrantly expressed kainate receptors in the hippocampus. This lead project is grounded in research from notable institutions, including INSERM, CNRS, Aix Marseille University, and the University of Bordeaux. Established in 2019, Corlieve Therapeutics aims to improve the quality of life for patients with refractory TLE by offering new therapeutic solutions.

Araris Biotech AG is a biotechnology start-up based in Zurich, Switzerland, founded in 2019. The company specializes in developing antibody-drug conjugate (ADC) linker technology aimed at enhancing chemotherapy by delivering drugs directly to targeted antibodies. This innovative approach allows for the creation of next-generation ADCs that are both safe and effective for treating various diseases, including cancer. Araris' platform enables the production of high-quality ADCs without the need for extensive engineering of antibodies or cell lines, allowing for rapid development and manufacturing processes. The technology is supported by two patents and focuses on site-specific conjugation, enabling the use of readily available antibodies. This streamlined production method facilitates quick quality control and analysis, enhancing the overall efficiency and reliability of ADC development.

NativeWaves is focused on enhancing the event viewing experience for audiences worldwide through its innovative audio synchronization and streaming technology. The company collaborates with partners to curate engaging content from live events and develops tools that facilitate personalized viewing experiences. By offering efficient and versatile content delivery solutions, NativeWaves allows for seamless integration into existing workflows without requiring major changes. Its software enables the translation of movies, sports events, and videos into multiple languages while eliminating issues such as buffering and synchronization delays. Additionally, users benefit from real-time access to live statistics and insights on alternate screens, allowing them to enjoy their favorite entertainment in a manner tailored to their preferences.

Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

Artiria Medical SA develops innovative micro-actuated devices aimed at treating vascular diseases, particularly in the brain. Founded in 2019 and based in Lausanne, Switzerland, the company focuses on enhancing the precision and control of surgical procedures involving catheters and guidewires. Its technology facilitates micromotion within brain arteries, thereby improving navigation during stroke treatments. By enabling surgeons to perform these complex procedures with greater accuracy, Artiria Medical contributes to better patient outcomes and the potential to save lives.

Doctorly GmbH is a health tech company based in Berlin, Germany, that specializes in a cloud-based practice management platform for healthcare professionals. Founded in 2017, Doctorly offers a comprehensive software-as-a-service solution designed to enhance efficiency and reduce costs for doctors. The platform includes features such as digital booking, video conferencing, electronic health records, and patient health analysis. Additionally, it facilitates seamless integration with other tools and workflows in the healthcare sector, allowing for improved connectivity between doctors and patients. Doctorly aims to drive meaningful change within the healthcare industry by providing innovative digital solutions that streamline practice management.

Agro.Club operates a comprehensive B2B global marketplace focused on the agricultural sector, primarily serving Europe, South America, and North America. The company aims to enhance the grain supply chain by utilizing technology to connect farmers and grain companies, thereby making food supply more secure, efficient, and sustainable. With over 40,000 farmers and thousands of international and domestic grain businesses using its platform, Agro.Club employs analytics to provide market transparency and algorithms to quickly match supply with demand. Its custom-built platform facilitates the entire transaction process, including quality control, logistics, and financing. As a result, Agro.Club has established itself as a unique marketplace in the agricultural industry and has achieved operational profitability.

Sympatient GmbH is a digital therapeutics company based in Hamburg, Germany, that specializes in virtual reality-based psychotherapy solutions for anxiety disorders. Founded in 2017, the company develops medical virtual reality applications aimed at enhancing mental health, particularly in anxiety and stress management. Its flagship products include Otemi, which helps users manage personal stress through various tasks and exercises, and Invirto, an application that provides therapeutic information and strategies for patients to independently treat their anxiety disorders at home. Sympatient also offers a CE-certified medical device for individuals diagnosed with anxiety disorders. By combining technology with traditional therapy methods, Sympatient aims to make mental health treatment more accessible and personalized for patients worldwide.

Accure Therapeutics S.L. is a pharmaceutical company based in Barcelona, Spain, focused on the development, production, and marketing of drugs aimed at treating central nervous system (CNS) diseases. As a clinical-stage research and development entity, Accure Therapeutics specializes in creating disease-modifying therapies for both severe orphan and non-orphan CNS disorders. The company is committed to accelerating the transition to effective treatments for disabling brain conditions, thereby enabling healthcare professionals to better address the complexities of CNS-related illnesses.

Schüttflix GmbH, founded in 2018 and based in Gütersloh, Germany, operates a digital marketplace and delivery platform for bulk construction supplies, including sand, crushed rock, and gravel. The platform serves as a logistics hub for the construction industry, connecting construction companies with suppliers, waste disposal firms, and freight carriers. By facilitating the ordering, tracking, and management of construction materials through its application, Schüttflix aims to minimize downtime and enhance project efficiency for its users.

Planetly is a Berlin-based company that provides software solutions for carbon management, enabling organizations to analyze, reduce, and offset their carbon footprints. The platform offers comprehensive insights into carbon emissions by collecting and processing data from various departments within a business. This analysis helps companies identify effective strategies for reducing emissions in a pragmatic manner. Planetly serves a diverse range of sectors, including banking, insurance, professional services, manufacturing, retail, and information technology. By promoting transparency and actionable strategies, Planetly aims to equip businesses with the tools necessary to fulfill their environmental responsibilities and contribute to addressing the climate crisis.

CALYXHA Biotechnologies GmbH is a biotechnology company founded in 2019 and based in Vienna, Austria. The company focuses on developing innovative therapies aimed at addressing tissue degeneration, which is a primary underlying factor in numerous significant human diseases. Through its research and development efforts, CALYXHA seeks to provide effective solutions to improve health outcomes related to these conditions.

Superscript is a digital insurance broker catering to businesses of all sizes, from startups to established enterprises. The company operates a self-serve online platform that allows small and medium-sized businesses to buy and manage their insurance quickly, often within minutes. As the first UK-based InsurTech to become a Lloyd’s of London broker, Superscript specializes in providing tailored coverage for innovative companies facing complex risks. Utilizing a price comparison tool and a flexible monthly subscription model, Superscript simplifies the insurance process, enabling users to generate quotes, set up coverage, and make adjustments or cancellations with ease.

Black Insurance is an innovative insurance platform that leverages blockchain technology to streamline the insurance industry. By connecting local managing general agents (MGAs), brokers, and agents directly with capital, Black removes traditional insurance companies from the value chain. This model allows local agents to design, price, and sell insurance products tailored to their markets while handling claims efficiently. The use of blockchain not only minimizes expenses and delays associated with conventional insurance processes but also enhances scalability by decentralizing business decisions, bringing them closer to the end customers. Black Insurance aims to transform the insurance landscape by offering a more agile and responsive alternative to traditional methods.

Motorpharma is focused on developing drug candidates that target motor proteins, with a particular emphasis on treating spasticity. The company provides drug development services aimed at simplifying research processes for healthcare professionals. By distributing enhanced myosin inhibitors, Motorpharma addresses symptoms associated with stroke and aids in the recovery of patients experiencing spasticity. This approach enables healthcare providers to better manage and treat the challenges faced by their patients in the aftermath of a stroke.

Intercontinental Capital is a premier cross-border financial advisory firm.

Motley London Ltd is a jewelry brand based in London, United Kingdom, founded in 2017. The company specializes in designing, manufacturing, and retailing a variety of jewelry items, including earrings, necklaces, rings, bracelets, and charms. Motley London distinguishes itself as a revolutionary e-commerce brand, offering products crafted by some of the world's top jewelry designers. Its offerings are available for purchase online, allowing customers to access unique and high-quality pieces directly from the brand.

Coindirect is a cryptocurrency trading platform focused on accelerating adoption across Africa and other emerging markets. Founded by a team from South Africa, it offers an end-to-end solution that allows users to buy and sell various cryptocurrencies directly on a peer-to-peer marketplace with 0% transaction fees. Users can engage in transactions using multiple payment methods, including credit cards, local bank transfers, and PayPal. Coindirect supports over 40 cryptocurrencies and altcoins, including ERC-20 tokens, and provides 15 trading pairs on its exchange platform. The service caters to a wide range of users, from first-time buyers to experienced investors, enabling them to securely manage their assets in one place. Additionally, Coindirect offers access to its underlying technology via an API for other fintech services. By bridging the gap between traditional finance and the cryptocurrency landscape, Coindirect aims to facilitate mainstream adoption of digital currencies.

Aleva Neurotherapeutics SA, founded in 2008 and based in Lausanne, Switzerland, specializes in the development of advanced implantable deep brain stimulation (DBS) systems. The company's product lineup includes directSTIM, an intelligent directional electrode designed to enhance the precision of electrical stimulation, and spiderSTIM, a diagnostic system that maps three-dimensional areas in brain targets to improve surgical outcomes. Additionally, Aleva is working on cortiSTIM, a device for cortical stimulation. Utilizing microelectromechanical systems (MEMS) technology, Aleva's devices aim to optimize existing therapies and enable the targeting of new brain areas, facilitating faster and more accurate surgical placements. The company focuses on treating neurological conditions such as Parkinson's disease and essential tremors. Aleva has successfully completed acute clinical trials for its products and is ISO13485 certified, reflecting its commitment to quality standards in medical device manufacturing. To date, Aleva has raised significant funding from various investors to support its ongoing development efforts.

ImCheck Therapeutics SAS is a biopharmaceutical company based in Marseille, France, founded in 2015. The company specializes in the development of immunotherapeutics aimed at addressing severe unmet medical needs, primarily in the field of immuno-oncology. ImCheck focuses on creating immuno-modulatory antibodies that target members of the butyrophilin super-family of checkpoint molecules, specifically engaging γ9δ2 T cells. Its research and development efforts are directed toward treating various cancers, including breast, gastric, and ovarian cancers, as well as other immune-related diseases. The company's innovative approach positions it at the forefront of next-generation immunotherapy solutions for patients suffering from solid tumors.

Peerbridge Health Inc. is a digital health company based in New York that specializes in remote monitoring of vital signs through its innovative wireless electrocardiogram (ECG) technology. The company has developed Peerbridge Cor, a multi-channel ECG monitor that provides physicians with real-time heart data and captures critical insights over a continuous seven-day period to aid in arrhythmia detection. In addition to Peerbridge Cor, the company offers Peerbridge CorHRV and Peerbridge Cor+, which monitor various vital signs including heart rate, respiratory rate, temperature, oxygen saturation, and heart rate variability (HRV). Peerbridge Health holds two patents related to medical-grade monitoring of vital signs, with additional patents pending, reflecting its commitment to enhancing healthcare delivery and patient outcomes through advanced technology. Founded in 2012, the company aims to improve the independence and precision of remote health monitoring for both medical and wellness applications.

Yonder AG is a Swiss company, founded in 2015 and based in Zurich, that specializes in documentation-as-a-service (DaaS) solutions. The company's primary offering, Yonder Mind, is an application software designed for information management, enabling organizations to create, maintain, and deliver relevant content to users efficiently. Yonder AG also offers services related to document content creation and conversion, helping clients streamline information dissemination through shorter documents and manageable revisions.

NovaGo Therapeutics AG is a biotechnology company based in Schlieren, Switzerland, focused on researching and developing human antibody therapeutics aimed at treating cerebral stroke and spinal cord injuries. The company specializes in creating recombinant human monoclonal antibodies that target Nogo-A, a nerve outgrowth inhibitor, to promote nerve repair and regeneration. NovaGo has established a strategic partnership with Neurimmune Holding AG, which allows access to a unique class of human-derived antibodies with significant therapeutic potential, developed through Neurimmune's Reverse Translational Medicine™ technology platform. Founded in 2015, NovaGo Therapeutics is dedicated to advancing innovative treatments for neurological conditions.

Sonect operates a financial platform that transforms local shops into virtual ATMs, allowing customers to withdraw and deposit cash conveniently using their smartphones. This location-based matchmaking service connects individuals seeking cash with nearby businesses willing to facilitate these transactions. By enabling local retailers to offer cash services, Sonect helps them attract new customers, earn commissions, and reduce the cash management burden. For users, the platform provides easy access to cash without the need for traditional ATMs, eliminating withdrawal fees and unnecessary trips. Additionally, banks benefit from reduced operational costs associated with ATMs and can expand their networks into new markets without significant capital investment. Overall, Sonect fosters a community-centric approach to cash distribution, benefiting consumers, local businesses, and financial institutions alike.

Doctify Limited operates an online platform that enables patients to search, compare, and book appointments with a wide range of healthcare specialists, including doctors in various fields such as cardiology, dermatology, and pediatrics. Founded in 2014 and headquartered in London, the platform allows users to filter their searches based on specialties, location, and availability, enhancing the ease of finding suitable medical care. Additionally, Doctify provides healthcare professionals with tools to manage their practices effectively, including features for collecting and displaying reviews, receiving peer recommendations, and minimizing appointment no-shows through automated reminders. The company has expanded into multiple markets and focuses on enhancing the patient experience by facilitating meaningful feedback and insights into healthcare services.

Mytos is focused on creating a fully automated cell manufacturing platform tailored for the biotech sector, specifically targeting the drug development industry. The company's technology employs automation to enhance the production of human cells, facilitating more efficient and adaptable cell culture processes. This innovative approach allows scientists to modify culturing protocols easily, leading to faster progress in cell growth and development. By streamlining these processes, Mytos aims to support pharmaceutical and biotech businesses in their research and production efforts.

medHF performs Human Factors research at Formative and Validation stages of medical device / combination product development.

YoFumo Technologies Inc. is a Denver-based company that specializes in manufacturing solutions for cannabis storage and processing. Founded in 2015, it provides a range of innovative technologies tailored to the cannabis industry. Its offerings include Yofumo Pro+, a comprehensive solution for post-trim curing, aging, storage, and management, as well as the Quad System, designed for post-harvest processing. Additionally, the company offers Yofumo Pro, which focuses on handling, environmental control, and monitoring of cannabis. YoFumo's patented technology aims to create a complete ecosystem for post-harvest decontamination and curation, with applications for various biomass types. This technology enhances the management of terpene curing and storage processes while ensuring product consistency and minimizing chemical residues.

BaseLaunch is a venture builder firm located in Basel, Switzerland, focused on launching and developing startups across various therapeutic sectors, including oncology, immunology, and cardiovascular health. The program spans 15 months and is divided into two phases, providing non-dilutive funding and access to a network of leading healthcare partners. Participants benefit from the expertise of seasoned advisors and state-of-the-art infrastructure, while being integrated into Basel's vibrant biotech ecosystem. BaseLaunch is supported by prominent industry leaders such as Johnson & Johnson Innovation, Novartis Venture Fund, Pfizer, Roche, and Roivant Sciences, along with various public and private collaborators.

In a constantly changing society, speed and assertiveness speak louder. Pocket devices help us to make decisions and save us time in choosing the right ones. We're constant updated about our favorite shows, favorite artists, fancy restaurants. The time has come for this to be replicated to our favorite neighborhood, our favorite city, our dream home/property. In an increasingly technological market, we believe in using artificial intelligence to provide an intelligent connection between SELLER and SEEKERS. Thinking this way, CASAFY brings to the market a POWERFUL App, which offers a fast and intelligent connection between both. The right properties for the right customer, at the right time in their lives. All this easily and accessible at the touch of a finger. This puts the real estate market once and for all in the 21st century, meaning no paperwork, making life easier for those who sell, those who intermediate and those who buy. Thus, we can offer a new proposal reaching from A-Z, from the low cost to the high luxury customer. Imagine seeing only what you want, without needing filters or wasting months searching for the ideal property. We do it for you, without you realizing it, because we have a clean interface with no advertisements. We aim to go where the eyes can't, using imagination and innovation to transform the reality of the entire real estate chain, from the construction company, through the intermediation of real estate and brokers, to the person who acquires the property . Casafy is online in Brazil, with over 1.2 million real estate sale and rental offers published!

Spiral Therapeutics, Inc. is a clinical-stage pharmaceutical company based in San Francisco, California, specializing in the development of therapies for inner ear disorders. Founded in 2016, the company focuses on delivering innovative drug therapies that target acute and subacute hearing loss, as well as balance disorders stemming from neurodegenerative, inflammatory, or vascular causes. By utilizing a platform that ensures the right medications are delivered to the appropriate site for the necessary duration, Spiral Therapeutics aims to provide effective treatments for individuals suffering from hearing disorders, ultimately enhancing their quality of life.

CheckYeti GmbH is an online platform and mobile application that facilitates the booking of ski instructors, ski schools, and mountain guides across various outdoor activities. Founded in 2014 and based in Vienna, Austria, CheckYeti offers users access to over 12,000 activity options in more than 1,000 mountain and beach destinations throughout Europe. The platform allows users to compare different instructors and guides based on reviews and pricing, enabling them to choose their preferred options. Additionally, it provides instructors and guides with enhanced visibility and the ability to interact directly with customers, as well as receive individual feedback. This comprehensive service caters to both winter and summer activities, including skiing, snowboarding, rafting, paragliding, and more, making it a valuable resource for holidaymakers and outdoor enthusiasts.

Rebio Technologies Limited, established in 2014 and based in Cranleigh, UK, is a biomedical company specializing in the development and manufacturing of bioresorbable polymers for medical devices and pharmaceuticals. It formulates and supplies multiple grades of these materials, catering to both medical device and active drug programs. Rebio's unique selling proposition lies in its proprietary polymer technology, which enables the efficient and cost-effective production of high-value chemicals through fermentation, addressing safety and efficacy challenges in sustained release approaches. The company's offerings include active drug programs and active medical device programs, with a focus on transforming the standard of care in various medical fields.

Public is a venture capital firm based in London, United Kingdom, focused on supporting technology startups that aim to enhance public services. Established in 2016, Public operates as an accelerator, providing capital, networks, insights, and support to help these startups thrive. One of its key initiatives is GovStart, a six-month growth program designed to cultivate a new pipeline of technology firms dedicated to transforming the public sector. Through this program and its broader support framework, Public seeks to foster innovation and improve the effectiveness of public services in the UK.

System1 Biosciences, Inc., founded in 2017 and headquartered in San Francisco, California, is a neurotherapeutics company focused on drug discovery for complex neurological and psychiatric diseases such as epilepsy, autism, and schizophrenia. By utilizing phenotypic screening, the company aims to overcome the limitations of existing discovery techniques in these challenging areas. System1 integrates cerebral organoid science, systems neuroscience, robotic automation, and advanced data analytics to achieve detailed characterizations of diseases, referred to as "deep phenotypes." These insights are employed to identify novel therapeutic targets and develop effective drug treatments.

Veesion is a company based in Paris, France, that specializes in gesture recognition technology aimed at detecting shoplifting in the retail sector. Founded in 2018, Veesion has developed an intelligent video surveillance software that employs deep learning algorithms to analyze the footage from security cameras in real-time. This technology identifies gestures associated with theft and sends alerts to human operators, who can then confirm the incident and respond appropriately. Veesion's solution integrates seamlessly with existing surveillance systems, providing retailers and distributors with an innovative and ethical means of safeguarding their assets while optimizing the allocation of security personnel.

GotCourts Ltd is a Zurich-based company that develops a software as a service (SaaS) platform dedicated to racquet sports. Founded in 2014, the platform serves as an online community for players, coaches, and court facility operators. It offers various services, including an online booking system for courts and coaches, a social network for connecting players, and tools for finding opponents and tracking progress. GotCourts aims to create the largest global hub for tennis and other racquet sports, facilitating interactions among enthusiasts and enhancing their sporting experience.

Lava Therapeutics B.V. is a biotechnology company based in Utrecht, the Netherlands, founded in 2016. The company specializes in developing proprietary bispecific antibodies aimed at engaging gamma-delta T cells for the treatment of both hematological and solid cancers. Its innovative platform, known as the Gammabody platform, is designed to create next-generation bispecific antibodies that activate the immune system to recognize and eliminate tumor cells. By harnessing the potential of γδ T cells, Lava Therapeutics aims to produce potent, safe, and cost-effective biopharmaceuticals that enhance the body's ability to combat cancer, thereby transforming the landscape of cancer treatment.

Wagz, Inc. is a pet technology company based in Portsmouth, New Hampshire, specializing in smart collars for dogs. Founded in 2015, the company offers the Wagz Collar, which combines GPS tracking, health monitoring, and location enforcement to keep dogs safe and connected with their owners. The collar features an activity monitor that tracks health and behavior, an LED light for visibility, and a high-definition live streaming camera that can be activated remotely or by bark detection. Additionally, Wagz provides the Wagz Serve Smart Feeder, which ensures dogs receive the proper nutrition at designated times, and mobile applications that allow users to manage collar settings, record medical data, and engage with a community of fellow dog owners. Wagz products are available through various resellers in the United States and online, catering to the needs of modern pet owners.

Houst, formerly known as Airsorted, is a short-term rental management service based in London, U.K. Founded in 2015, the company specializes in providing a comprehensive platform for homeowners looking to maximize their rental income while minimizing the complexities associated with short-let hosting. Houst manages various aspects of property letting, including listing creation, pricing optimization, marketing, and guest management. By automating these processes, the company aims to deliver a hassle-free experience for homeowners, allowing them to achieve higher rental yields without the stress of day-to-day operations. With a mission to simplify home-sharing, Houst caters to both individual homeowners and the broader market by promoting efficient and effective rental practices.

NRx Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing innovative therapeutics for central nervous system disorders and life-threatening pulmonary diseases. The company aims to address serious medical conditions that often lack effective treatments. It has commercialized ZYESAMI (Aviptadil), a therapeutic for COVID-related respiratory failure, and is advancing NRX-100/101, which represents the first sequential drug regimen targeting bipolar depression in patients experiencing acute suicidal ideation and behavior. Additionally, NRx Pharmaceuticals has been awarded exclusive worldwide rights by the Government of Israel to develop and market the BriLife COVID vaccine, enhancing its portfolio in the fight against respiratory illnesses.

Heist Studios Limited is a London-based company that specializes in manufacturing women's tights, aiming to redefine the traditional bodywear market. Founded in 2014, Heist Studios operates primarily online and has quickly gained traction, selling over 100,000 pairs of tights within its first year. The business has experienced significant growth, achieving a month-on-month increase of 25%. Heist Studios has garnered recognition in the fashion industry, with notable endorsements from publications such as Vogue and STYLE magazine, which praised its products for their quality and innovation.

Loma provides search for all the secondhand, rent and repair sites in one click.

Triple Dragon is a financial services provider specializing in facilitating the growth of game and application developers, as well as publishers, through user acquisition loans. The company offers a range of flexible investment products designed to fund marketing campaigns and user acquisition efforts, allowing clients to expand their install base and boost revenue without relinquishing equity. By supporting the financing needs of gaming technology stakeholders, Triple Dragon helps its clients launch and scale their projects effectively, contributing to their overall business growth.

DF Capital specializes in building relationships with manufacturers and offering working capital solutions throughout supply chains. By providing flexible finance products, DF Capital assists businesses in driving their growth and aligning their cash cycle with lending terms. This approach allows companies to effectively manage cash flow and meet their financial needs for continued expansion and success.

Vertus Capital provides capital to help facilitate the sale and purchase of advice firms.

UV Light Care, Inc. is a medtech company based in Boston, Massachusetts, established in 2015. The company specializes in ultraviolet light technology, focusing on its applications in disinfection and various medical settings. UV Light Care has developed innovative disinfection solutions targeting vascular access devices and indwelling catheters, addressing critical unmet needs within the medical community. Through its advancements in UV light technology, the company aims to enhance infection control and improve patient outcomes in healthcare environments.

AdaptHealth is a provider of patient-centered healthcare-at-home solutions, specializing in home medical equipment (HME), medical supplies, and associated services. The company distributes a wide range of clinically driven products designed to support patients in living independently, including sleep and respiratory therapy equipment, mobility aids, wound care supplies, and nutrition services. AdaptHealth also offers vital services such as continuous glucose monitoring and insulin pumps for diabetes management, as well as oxygen and chronic therapy services. Founded in 2012 and headquartered in Phoenixville, Pennsylvania, the company serves patients and healthcare institutions across several states, including Pennsylvania, New Jersey, New York, Maryland, and Delaware. Additionally, AdaptHealth provides online bill payment services to assist patients in managing their medical equipment expenses.

omicX operates a platform that facilitates access to bioinformatics tools for scientists and developers. Founded in 2012 and based in Le Petit Quevilly, France, the company offers OMICtools, a resource designed to help users navigate the vast array of biotechnology tools available. By leveraging collective intelligence in bioinformatics, omicX aims to exploit biological Big Data across various applications, including biotechnology, life sciences, medicine, agriculture, and industry. The platform not only provides information on tools for managing and analyzing extensive biological data but also fosters interaction within the scientific community by allowing users to pose questions, share expertise, and provide feedback on tools. This approach has established omicX as a trusted leader and reference point in bioinformatics, attracting users from prominent universities, medical institutions, pharmaceutical companies, and the biotech industry.

Bricksave is a global real estate investment platform that facilitates access to property investments around the world. It offers a curated selection of unique properties in prime locations such as Miami, London, and Paris, enabling both first-time and experienced investors to participate with a minimum investment of $1,000. The platform is designed to streamline the investment process, allowing users to manage their investments quickly and efficiently, without the need for human interaction. Investors can benefit from rental income and potential capital gains from property sales, while Bricksave handles the ongoing management of the properties. This approach allows investors to diversify their portfolios and achieve competitive, secure returns with minimal effort.

Frontier Car Group is a Berlin-based startup focused on developing and operating used automotive marketplaces in emerging markets, including Nigeria, Mexico, Argentina, Colombia, Chile, Pakistan, and Indonesia. The company aims to simplify the process of buying and selling used cars through its online platform, which features a digital quote engine that provides instant pricing for vehicles. This technology not only enhances the efficiency of transactions but also facilitates quick vehicle inspections at designated locations. By leveraging innovative business models and infrastructure, Frontier Car Group is able to create value for all stakeholders involved in the used car market. Additionally, the company is engaged in joint ventures with OLX in India and Poland, further expanding its reach and impact in the automotive sector.

Mavencare Inc. is a home care services provider based in Toronto, Canada, with additional locations in Calgary, Ottawa, and Edmonton. The company offers a comprehensive range of services designed to support seniors in aging at home, including companionship, housekeeping, meal preparation, personal care, specialized nursing care, and support for conditions such as Alzheimer’s, dementia, and Parkinson’s. Founded by individuals who faced challenges in securing quality home care for their own grandparents, Mavencare aims to address the needs of the nearly 90 percent of seniors who wish to remain in their homes as they age. The company leverages technology to enhance caregiver vetting, match clients with appropriate caregivers, and facilitate communication among families and care providers, ensuring that seniors feel connected and well-cared for. By utilizing data and machine learning, Mavencare seeks to identify potential risks and improve the overall quality of home care.

PlayStack is a game publishing company dedicated to supporting developers in realizing their creative visions. Established on the belief that talented developers often need assistance, PlayStack offers a range of services to facilitate their success. These include comprehensive funding, expert publishing guidance, and technological support aimed at building strong gaming audiences and communities. Drawing on years of experience in leading, producing, and publishing successful games, PlayStack provides the necessary resources and knowledge to help developers effectively navigate the journey from concept to global recognition. Through its commitment to fostering innovative games, PlayStack enables creators to approach their projects with confidence and strategic direction.

Homeshift builds a simple online dashboard that lets users see their existing services. They design homes and services from scratch. They provide services in internet, energy, water, and council.

Iproteos is a biotechnology company specializing in the research and development of innovative therapeutic strategies targeting protein-ligand and protein-protein interactions through the use of peptidomimetics. Utilizing its proprietary IPRO technology, Iproteos focuses on discovering therapeutic agents for diseases affecting the central nervous system, including conditions like schizophrenia, epilepsy, and pediatric cancer. The company's expertise in developing third-generation drugs positions it as a valuable partner for organizations seeking to advance their own therapeutic targets. Through its commitment to addressing complex neurological disorders, Iproteos aims to contribute significantly to the field of medicine.

KB Medical SA is a Swiss company that specializes in the design, development, and marketing of robotic assistance systems for the healthcare industry, particularly in spinal surgery. Founded in 2012 and based in Ecublens, Switzerland, the company offers the AQrate robotic system, which assists surgeons during spinal fusion procedures. This technology enhances surgical precision, reduces the risk of complications, and minimizes radiation exposure for the operating room team. By providing a less hazardous work environment, KB Medical aims to improve patient outcomes and quality of life post-surgery while also lowering overall treatment costs. The company’s operations comply with ISO 13485 standards, ensuring quality in the design and manufacture of its robotic systems. In 2017, KB Medical became a subsidiary of Globus Medical, Inc.

Pockit Limited is a fintech company based in London, United Kingdom, that offers financial services primarily to individuals who are often excluded or underserved by traditional banks. Established in 2010, Pockit provides a prepaid MasterCard along with an online account that enables customers to receive their wages and benefits directly. Users can fund their accounts through various methods, including debit cards and bank transfers, at multiple locations across the UK. The company also offers a mobile application for both iPhone and Android devices, allowing customers to manage their finances conveniently. Pockit's services extend to in-store, online, and international usability, as well as cashback savings solutions, making it a comprehensive option for those seeking accessible banking alternatives.

3Derm Systems, Inc. is a Boston-based company that specializes in 3D dermatology solutions. Founded in 2011, it has developed a handheld skin imager along with cloud-based software that enables users to capture, store, and transmit high-resolution 3D images of the skin to dermatologists. This innovative system allows non-dermatologists to take clinical-quality images remotely, facilitating efficient monitoring of skin conditions, particularly for patients at risk of skin cancer. By enabling images to be reviewed at medical kiosks and other referral sites, 3Derm helps dermatologists manage high patient volumes while reserving in-office visits for those requiring immediate attention. The company's approach aims to reduce healthcare costs, decrease wait times, and enhance access to dermatological care, allowing patients to monitor their skin from home instead of making frequent, often inconvenient, clinic appointments. 3Derm Systems operates as a subsidiary of Digital Diagnostics, Inc. as of August 2020.

Memory AS, a Norwegian startup based in Oslo, specializes in developing innovative tools aimed at enhancing productivity in the workplace. Established in 2013, the company is known for its flagship product, Timely, which is recognized as the world's first AI-powered time tracking and planning tool. In addition to Timely, Memory has launched Dewo, a personal assistant designed to facilitate deep work. By leveraging artificial general intelligence, Memory AS focuses on creating solutions that promote a better work-life integration and improve overall efficiency.

Integrity Implants focuses in developing unique expandable interbody technology. The company's goal is to make the lives of customers better through advances in minimally invasive procedures. Integrity Implants constructs innovative technologies and products that can contribute to the enhancement of patient and hospital outcomes as it pertains to orthopedics and spine. Integrity Implants was founded 2016 and is headquarters Jupiter, Florida.

Prettysocial media International GmbH, headquartered in Munich, Germany, specializes in online content marketing services. The company facilitates monetization of clients' and publishers' social media presence by developing and distributing sophisticated content marketing concepts across various social channels. It combines advanced technology with business intelligence to deliver insights, strategies, and results in social and digital marketing. Prettysocial's Native Avenue Platform uniquely connects brands with a network of leading publishers, enabling complex content marketing campaigns.

Flyability SA is a Swiss company founded in 2014 and based in Lausanne, specializing in the development and manufacturing of flying robots designed for industrial inspections in inaccessible and confined spaces. The company’s flagship product, Elios, is a collision-tolerant flying robot that allows for safe inspections in complex environments, such as within buildings and urban areas, reducing the need for human presence in hazardous situations. Flyability’s technology addresses critical issues in the rapidly growing drone industry, particularly concerning collision and injury risks. Its applications extend beyond industrial inspections to include search and rescue operations and security assessments, enabling professionals to gather vital data while ensuring safety. The company has received numerous accolades, including the Drones for Good Award, reflecting its commitment to innovation and societal impact.